Clinically Tested Probiotic-Based Cosmeceutical Ingredient Debuts

March 20, 2012

While not all probiotic ingredients in the skincare market may have research data supporting claims, Ganeden Biotech’s new, patented Bonicel topical antiaging probiotic-based ingredient has clinical data demonstrating skin improvements.

While not all probiotic ingredients in the skincare market may have research data supporting claims, probiotics supplier Ganeden Biotech’s (Cleveland, OH) new, patented Bonicel topical antiaging probiotic-based ingredient has clinical data demonstrating improvements in skin hydration, elasticity, under-eye puffiness, and reduced fine lines and wrinkles. The company cites a double-blind, placebo-controlled study, conducted on female subjects ages 35 to 60, showing that at four weeks, Bonicel improved skin hydration by 16% and skin elasticity by 11%, and decreased fine lines and wrinkles, in 50% of subjects.

The ingredient can be used in topical lotions, creams, gels, powders, scrubs, masks, and cleansers. The company says that unlike most probiotic ingredients, including Lactobacillus and Bifidobacterium, Bonicel can be easily included in formulations.

Bonicel is derived from the company’s well-documented probiotic strain Ganeden BC30 (Bacillus coagulans GBI-30, 6086) and is produced naturally during Ganeden BC30’s fermentation process. The company says it utilizes proprietary processes to optimize the metabolic activity of the fermenting organism to produce maximum amounts of naturally derived L+ Lactic acid, bacteriocins, hydrogen peroxide, enzymes, and other metabolites.

“Over the years, we have watched companies launch so-called probiotic topical products without data supporting efficacy or safety,” said Sean Farmer, the company’s founder and chief science officer, to the press. “With the launch of Bonicel, we can make use of our IP and years of experience in this space to help cosmetic manufacturers produce quality, effective products.”

“We are excited to add Bonicel to our branded ingredient portfolio,” added Michael Bush, vice president of business development. “We have been watching the cosmeceutical space for several years and think the time is right to introduce a scientifically backed, patented, and branded ingredient into this important market.”